Summary
Overview
Work history
Education
Skills
Additional Information
Certification
Publication
Timeline
Generic

Nasser Alaqel

Buraydah, Qassim,Saudi Arabia

Summary

Medical director at Prince Faisal Cancer Center, Buraydah.Qassim, Saudi Arabia.

Medical Oncology Consultant at PFCC.

Overview

21
21
years of professional experience
1
1
Certification

Work history

Medical Director

Prince Faisal Cancer Center
Buraydah, Saudi Arabia
2024.02 - Current

Medical Oncology Consultant

Princs Faisal Cancer Center
Buraydah, Qassim
2023.02 - Current

Medical Oncology Consultant

Security Forces Hospital
Riyadh, Saudi Arabia
2020.01 - 2023.01

Medical Oncology consultant

King Salman Specialist Hospital
Hail, Saudi Arabia
2019.05 - 2019.12

Medical Oncology Fellow then Associate Consultant

King Abdullah Medical City
Makkah, Saudi Arabia
2015.01 - 2019.02

Internal Medicine Resident

King Abdul Aziz Hospital
Taif, Saudi Arabia
2013.10 - 2014.12

Senior Resident (R3-R4)

Internal Medicine Resident

King Fahad Hospital
Albaha, Saudi Arabia
2009.12 - 2011.09
  • Junior Resident (R1-R2)

Internal Medicine Physician

Althager Hospital
Jeddah, Saudi Arabia
2005.01 - 2009.01

Education

Bachelor of Medicine,Bachelor of Surgery -

Aden University
Aden, Yamen
2001.04 -

Skills

  • Team Player
  • Motivated
  • Patient Advocate
  • Enthusiastic
  • Work under pressure
  • Flexible

Additional Information

Language : Arabic , English

Marital Status: Married

Certification

  • Saudi Board in Internal Medicine 10-2009 till 12-2013
  • Saudi Fellowship in Medical Oncology 01-2015 till 12-2016
  • BLS
  • ACLS
  • FCCS

Publication

- A disease registry study to observe treatment effect in HER2 positive unresectable or metastatic breast cancer. article  july 2017

 - observational study for treatment response in high grade glioma with MGMT negative tumor. august 2018.

- Efficacy and prognostic significance of triflurodine/tipiracil beyond oxaliplatin and irinotecan based chemotherapy in patients with refractory metastatic colorectal cancer: An observational multicenter study: ASCO Abstract 2021 .

- Efiicacy and tolerability of Cetuximab 750mg/m2 every 3 weeks in metastatic colorectal cancer, articl jun 2023.

- Prospective validation study of COMPASS-CAT model for symptomatic venous thromboembolism risk in cancer patients. april 2024.

Timeline

Medical Director

Prince Faisal Cancer Center
2024.02 - Current

Medical Oncology Consultant

Princs Faisal Cancer Center
2023.02 - Current

Medical Oncology Consultant

Security Forces Hospital
2020.01 - 2023.01

Medical Oncology consultant

King Salman Specialist Hospital
2019.05 - 2019.12

Medical Oncology Fellow then Associate Consultant

King Abdullah Medical City
2015.01 - 2019.02

Internal Medicine Resident

King Abdul Aziz Hospital
2013.10 - 2014.12

Internal Medicine Resident

King Fahad Hospital
2009.12 - 2011.09

Internal Medicine Physician

Althager Hospital
2005.01 - 2009.01

Bachelor of Medicine,Bachelor of Surgery -

Aden University
2001.04 -
Nasser Alaqel